NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Hypertrophic response to hemodynamic overload: role of load vs. renin-angiotensin system activationMyocardial hypertrophy is one of the basic mechanisms by which the heart compensates for hemodynamic overload. The mechanisms by which hemodynamic overload is transduced by the cardiac muscle cell and translated into cardiac hypertrophy are not completely understood. Candidates include activation of the renin-angiotensin system (RAS) and angiotensin II receptor (AT1) stimulation. In this study, we tested the hypothesis that load, independent of the RAS, is sufficient to stimulate cardiac growth. Four groups of cats were studied: 14 normal controls, 20 pulmonary artery-banded (PAB) cats, 7 PAB cats in whom the AT1 was concomitantly and continuously blocked with losartan, and 8 PAB cats in whom the angiotensin-converting enzyme (ACE) was concomitantly and continuously blocked with captopril. Losartan cats had at least a one-log order increase in the ED50 of the blood pressure response to angiotensin II infusion. Right ventricular (RV) hypertrophy was assessed using the RV mass-to-body weight ratio and ventricular cardiocyte size. RV hemodynamic overload was assessed by measuring RV systolic and diastolic pressures. Neither the extent of RV pressure overload nor RV hypertrophy that resulted from PAB was affected by AT1 blockade with losartan or ACE inhibition with captopril. RV systolic pressure was increased from 21 +/- 3 mmHg in normals to 68 +/- 4 mmHg in PAB, 65 +/- 5 mmHg in PAB plus losartan and 62 +/- 3 mmHg in PAB plus captopril. RV-to-body weight ratio increased from 0.52 +/- 0.04 g/kg in normals to 1.11 +/- 0.06 g/kg in PAB, 1.06 +/- 0.06 g/kg in PAB plus losartan and 1.06 +/- 0.06 g/kg in PAB plus captopril. Thus 1) pharmacological modulation of the RAS with losartan and captopril did not change the extent of the hemodynamic overload or the hypertrophic response induced by PAB; 2) neither RAS activation nor angiotensin II receptor stimulation is an obligatory and necessary component of the signaling pathway that acts as an intermediary coupling load to the hypertrophic response; and 3) load, independent of the RAS, is capable of stimulating cardiac growth.
Document ID
20040142086
Acquisition Source
Legacy CDMS
Document Type
Reprint (Version printed in journal)
Authors
Koide, M.
(Gazes Cardiac Research Institute, Medical University of South Carolina, Veterans Affairs Medical Center Charleston, South Carolina 29401, United States)
Carabello, B. A.
Conrad, C. C.
Buckley, J. M.
DeFreyte, G.
Barnes, M.
Tomanek, R. J.
Wei, C. C.
Dell'Italia, L. J.
Cooper, G. 4th
Zile, M. R.
Date Acquired
August 22, 2013
Publication Date
February 1, 1999
Publication Information
Publication: The American journal of physiology
Volume: 276
Issue: 2 Pt 2
ISSN: 0002-9513
Subject Category
Life Sciences (General)
Report/Patent Number
ISSN: 0002-9513
Funding Number(s)
CONTRACT_GRANT: P01-HL-48788
Distribution Limits
Public
Copyright
Other
Keywords
Non-NASA Center
NASA Discipline Cardiopulmonary
Renin-Angiotensin System/physiology
Hypertrophy, Right Ventricular/etiology/pathology/physiopathology
Hypertension/complications/physiopathology
Pulmonary Artery/physiopathology
Support, U.S. Gov't, P.H.S
Cats
Myocardium/metabolism/pathology
Myocardial Contraction/drug effects
Angiotensin-Converting Enzyme Inhibitors/pharmacology
Hemodynamic Processes/drug effects/physiology
Elasticity/drug effects
Animals
Antihypertensive Agents/pharmacology
Losartan/pharmacology
Heart/drug effects/physiopathology
Angiotensin II/metabolism
Captopril/pharmacology
Support, U.S. Gov't, Non-P.H.S
Blood Pressure/drug effects
Constriction, Pathologic

Available Downloads

There are no available downloads for this record.
No Preview Available